EMAIL THIS PAGE TO A FRIEND

PloS one

FGF/FGFR2 signaling regulates the generation and correct positioning of Bergmann glia cells in the developing mouse cerebellum.


PMID 24983448

Abstract

The normal cellular organization and layering of the vertebrate cerebellum is established during embryonic and early postnatal development by the interplay of a complex array of genetic and signaling pathways. Disruption of these processes and of the proper layering of the cerebellum usually leads to ataxic behaviors. Here, we analyzed the relative contribution of Fibroblast growth factor receptor 2 (FGFR2)-mediated signaling to cerebellar development in conditional Fgfr2 single mutant mice. We show that during embryonic mouse development, Fgfr2 expression is higher in the anterior cerebellar primordium and excluded from the proliferative ventricular neuroepithelium. Consistent with this finding, conditional Fgfr2 single mutant mice display the most prominent defects in the anterior lobules of the adult cerebellum. In this context, FGFR2-mediated signaling is required for the proper generation of Bergmann glia cells and the correct positioning of these cells within the Purkinje cell layer, and for cell survival in the developing cerebellar primordium. Using cerebellar microexplant cultures treated with an FGFR agonist (FGF9) or antagonist (SU5402), we also show that FGF9/FGFR-mediated signaling inhibits the outward migration of radial glia and Bergmann glia precursors and cells, and might thus act as a positioning cue for these cells. Altogether, our findings reveal the specific functions of the FGFR2-mediated signaling pathway in the generation and positioning of Bergmann glia cells during cerebellar development in the mouse.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA035305
Anti-FGFR2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500889
Anti-FGFR2 antibody produced in rabbit, affinity isolated antibody
AV38062
Anti-PAX6 (AB1) antibody produced in rabbit, affinity isolated antibody
AV32741
Anti-PAX6 (AB2) antibody produced in rabbit, affinity isolated antibody
SAB1406221
Anti-PAX6 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA030775
Anti-PAX6 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410879
Anti-PAX6 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA015768
Anti-S100B antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106315
Anti-S100B antibody produced in rabbit, affinity isolated antibody, lyophilized powder
Y0000441
Didanosine impurity A,, European Pharmacopoeia (EP) Reference Standard
C5H4N4O
SRP3308 FGF-9 human, Animal-component free, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
SRP3040 FGF-9 human, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), cell culture tested
SAB5300039
Monoclonal Anti-PAX6 antibody produced in mouse, clone 1C8, ascites fluid